XBiotech (XBIT) Competitors $6.83 +0.21 (+3.17%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends XBIT vs. NLTX, FLXN, TYRA, EOLS, CRON, RLAY, PLRX, PRTA, AUTL, and AVXLShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include Neoleukin Therapeutics (NLTX), Flexion Therapeutics (FLXN), Tyra Biosciences (TYRA), Evolus (EOLS), Cronos Group (CRON), Relay Therapeutics (RLAY), Pliant Therapeutics (PLRX), Prothena (PRTA), Autolus Therapeutics (AUTL), and Anavex Life Sciences (AVXL). These companies are all part of the "medical" sector. XBiotech vs. Neoleukin Therapeutics Flexion Therapeutics Tyra Biosciences Evolus Cronos Group Relay Therapeutics Pliant Therapeutics Prothena Autolus Therapeutics Anavex Life Sciences Neoleukin Therapeutics (NASDAQ:NLTX) and XBiotech (NASDAQ:XBIT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability, earnings and community ranking. Which has higher valuation & earnings, NLTX or XBIT? XBiotech has higher revenue and earnings than Neoleukin Therapeutics. Neoleukin Therapeutics is trading at a lower price-to-earnings ratio than XBiotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeoleukin TherapeuticsN/AN/A-$57.56M-$3.11-6.53XBiotech$4.01M51.91-$24.56M-$1.08-6.32 Does the media favor NLTX or XBIT? In the previous week, XBiotech had 1 more articles in the media than Neoleukin Therapeutics. MarketBeat recorded 1 mentions for XBiotech and 0 mentions for Neoleukin Therapeutics. XBiotech's average media sentiment score of 1.11 beat Neoleukin Therapeutics' score of 0.00 indicating that XBiotech is being referred to more favorably in the news media. Company Overall Sentiment Neoleukin Therapeutics Neutral XBiotech Positive Which has more risk & volatility, NLTX or XBIT? Neoleukin Therapeutics has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, XBiotech has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Do insiders and institutionals have more ownership in NLTX or XBIT? 52.4% of Neoleukin Therapeutics shares are owned by institutional investors. Comparatively, 55.7% of XBiotech shares are owned by institutional investors. 1.6% of Neoleukin Therapeutics shares are owned by company insiders. Comparatively, 33.1% of XBiotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor NLTX or XBIT? XBiotech received 267 more outperform votes than Neoleukin Therapeutics when rated by MarketBeat users. Likewise, 69.98% of users gave XBiotech an outperform vote while only 45.87% of users gave Neoleukin Therapeutics an outperform vote. CompanyUnderperformOutperformNeoleukin TherapeuticsOutperform Votes5045.87% Underperform Votes5954.13% XBiotechOutperform Votes31769.98% Underperform Votes13630.02% Is NLTX or XBIT more profitable? XBiotech's return on equity of -15.99% beat Neoleukin Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Neoleukin TherapeuticsN/A -37.22% -30.91% XBiotech N/A -15.99%-14.85% SummaryXBiotech beats Neoleukin Therapeutics on 13 of the 13 factors compared between the two stocks. Ad Brownstone ResearchShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Click here for full details. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$208.18M$6.61B$5.21B$8.85BDividend YieldN/A8.14%5.53%4.08%P/E Ratio-6.325.6173.5814.36Price / Sales51.91357.111,248.4887.29Price / CashN/A53.8240.8336.89Price / Book1.0810.617.196.54Net Income-$24.56M$153.27M$119.47M$226.15M7 Day Performance2.55%3.98%2.11%3.76%1 Month Performance-4.34%-6.72%-2.45%4.63%1 Year Performance90.78%33.26%34.51%29.20% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech0.8954 of 5 stars$6.83+3.2%N/A+90.8%$208.18M$4.01M-6.32100Positive NewsNLTXNeoleukin TherapeuticsN/A$20.30+30.2%N/A+46.3%$190.78MN/A-6.5390High Trading VolumeFLXNFlexion TherapeuticsN/A$9.12flatN/AN/A$458.93M$85.55M-4.54257TYRATyra Biosciences2.9546 of 5 stars$15.83+3.1%$31.00+95.8%+38.7%$801.00MN/A-9.8320EOLSEvolus4.0515 of 5 stars$12.60-3.4%$23.00+82.5%+34.0%$797.83M$202.09M0.00170CRONCronos Group1.8104 of 5 stars$2.08+1.5%$3.00+44.2%+4.0%$795.18M$87.24M-16.00356RLAYRelay Therapeutics3.3215 of 5 stars$4.75+2.4%$21.22+346.8%-41.1%$795.06M$25.55M0.00304News CoverageHigh Trading VolumePLRXPliant Therapeutics3.5294 of 5 stars$12.98+1.0%$40.57+212.6%-6.8%$789.83M$1.58M0.0090PRTAProthena1.6694 of 5 stars$14.60+1.1%$61.86+323.7%-55.4%$785.63M$91.37M0.00173Analyst DowngradeAUTLAutolus Therapeutics3.5289 of 5 stars$2.94+3.5%$10.15+245.2%-34.4%$782.31M$1.70M0.00330AVXLAnavex Life Sciences3.7649 of 5 stars$9.11+1.0%$40.00+339.1%+36.0%$772.53MN/A0.0040Upcoming Earnings Related Companies and Tools Related Companies NLTX Competitors FLXN Competitors TYRA Competitors EOLS Competitors CRON Competitors RLAY Competitors PLRX Competitors PRTA Competitors AUTL Competitors AVXL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XBIT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBIT Stock Alerts